Lipid signatures of unstable atheromas fossils or a step toward personalized lipidomics-metabolomics?

Circulation: Cardiovascular Genetics

Volumn 4, Issue 3, 2011, Pages 215-217

  Spite, Matthew ^b   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LINOLEIC ACID; LIPID; LIPOXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SPHINGOLIPID; THROMBOXANE SYNTHASE; TRIACYLGLYCEROL;

ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; DIET; DISEASE COURSE; ENDARTERECTOMY; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIA; LEUKOCYTE; LIFESTYLE MODIFICATION; LIPID PEROXIDATION; LIPIDOMICS; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; STROKE; THROMBOGENESIS;

ANIMALS; CARDIOVASCULAR DISEASES; FOSSILS; HUMANS; LIPID METABOLISM; LIPIDS; MASS SPECTROMETRY; METABOLOMICS; PLAQUE, ATHEROSCLEROTIC;

EID: 80052749402     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.111.960344     Document Type: Review

References (20)

1. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802-815.
2. Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001;104:914-920. (Pubitemid 32778043)
3. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36-46.
4. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204-212.
5. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 2008;22:3595-3606.
6. Qiu H, Gabrielsen A, Agardh HE, Wan M, Wetterholm A, Wong CH, Hedin U, Swedenborg J, Hansson GK, Samuelsson B, Paulsson-Berne G, Haeggstrom JZ. Expression of 5-lipoxygenase and leukotriene a4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A. 2006;103:8161-8166. (Pubitemid 43801069)
7. Gabrielsen A, Qiu H, Back M, Hamberg M, Hemdahl AL, Agardh H, Folkersen L, Swedenborg J, Hedin U, Paulsson-Berne G, Haeggstrom JZ, Hansson GK. Thromboxane synthase expression and thromboxane a2 production in the atherosclerotic lesion. J Mol Med. 2010;88:795-806.
8. Brezinski DA, Nesto RW, Serhan CN. Angioplasty triggers intracoronary leukotrienes and lipoxin a4: impact of aspirin therapy. Circulation. 1992; 86:56-63.
9. Pettinella C, Lee SH, Cipollone F, Blair IA. Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850:168-176. (Pubitemid 46618162)
10. Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, Hartvigsen K, Boullier A, Gonen A, Diehl CJ, Que X, Montano E, Shaw PX, Tsimikas S, Binder CJ, Witztum JL. Oxidation-specific epitopes are dangerassociated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011;108:235-248.
11. Clish CB, Serhan CN. Lipidomic Analysis of Plasma and Tissues: Lipid-Derived Mediators of Inflammation and Markers of Disease. In: Burczynski ME, Rockett JC, eds. Surrogate Tissue Analysis: GENOMIC, PROTEOMIC and Metabolomic Approaches. Boca Raton, FL: Taylor & Francis; 2006:185-202.
12. Stegemann C, Drozdov I, Shalhoub J, Humphries J, Ladroue C, Didangelos A, Baumert M, Allen M, Davies AH, Monaco C, Smith A, Xu Q, Mayr M. Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet. 2011;4:232-242.
13. Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res. 2010;107: 1170-1184.
14. Merched AJ, Serhan CN, Chan L. Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis. J Nutrigenet Nutrigenomics. 2011;4:12-24.
15. Gertow K, Nobili E, Folkersen L, Newman JW, Pedersen TL, Ekstrand J, Swedenborg J, Kuhn H, Wheelock CE, Hansson GK, Hedin U, Haeggstrom JZ, Gabrielsen A. Twelve-and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis. 2011;215:411-416.
16. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin e1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol. 2010;177:2116-2123.
17. Subbarao K, Jala VR, Mathis S, Suttles J, Zacharias W, Ahamed J, Ali H, Tseng MT, Haribabu B. Role of leukotriene b4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004;24:369-375. (Pubitemid 38197592)
18. Back M, Bu DX, Branstrom R, Sheikine Y, Yan ZQ, Hansson GK. Leukotriene b4 signaling through NF-kappaB-dependent blt1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci U S A. 2005;102:17501-17506. (Pubitemid 41740895)
19. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol. 2003;171:6856-6865. (Pubitemid 37532121)
20. Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med. 2004;14:191-195. (Pubitemid 38942827)